efgartigimod

ASH: With immune thrombocytopenia win, argenx proves efgartigimod's no one-trick pony in autoimmune disease
Fierce Pharma
Sun, 12/11/22 - 01:32 pm
ASH 2022
ITP
efgartigimod
Argenx
Argenx Scores Priority Review for Generalized Myasthenia Gravis Therapeutic
BioSpace
Tue, 11/22/22 - 04:30 pm
Argenx
FDA
priority reviews
myasthenia gravis
efgartigimod
Seeking sibling for Vyvgart, argenx files for FDA approval of subcutaneous efgartigimod
Fierce Pharma
Tue, 09/27/22 - 10:16 am
Argenx
Vyvgart
myasthenia gravis
efgartigimod
FDA
Data and regulatory roundup: Pfizer’s feat, an ADHD miss, Eli Lilly’s CRL & more
MedCity News
Mon, 03/28/22 - 10:17 am
FDA
Pfizer
etrasimod
Argenxy
efgartigimod
Aligos Therapeutics
Vallon Pharmaceuticals
Adderall
ORIC Pharmaceuticals
ORIC-101
Neurana Pharmaceuticals
tolperisone
Eli Lilly
sintilimab
Argenx takes a step towards convenience
EP Vantage
Wed, 03/23/22 - 10:27 am
Argenx
efgartigimod
Vyvgart
myasthenia gravis
Go or no go? Argenx's December showdown
EP Vantage
Wed, 12/1/21 - 10:10 am
FDA
Argenx
efgartigimod
myasthenia gravis
Calliditas
Nefcon
Merck
Keytruda
From Pfizer to Argenx: A look at potential blockbusters awaiting FDA decisions this year
Fierce Pharma
Mon, 09/13/21 - 11:38 pm
FDA
Pfizer
Argenx
UCB Pharma
Roche
efgartigimod
bimekizumab
faricimab
abrocitinib
Aducanumab tops 2021’s biggest potential launches
EP Vantage
Mon, 01/18/21 - 01:04 pm
drug launches
Biogen
Eisai
aducanumab
efgartigimod
Argenx
Evrenzo
FibroGen
Astellas
AstraZeneca
Leqvio
Novartis
UCB Pharma
bimekizumab
Ascendis Pharma
Bluebird Bio
Bristol-Myers Squibb
ide-cel
liso-cel
AXS-05
Axsome Therapeutics
voclosporin
Aurinia
Belgium biotech argenx nabs Bayer speedy review voucher for a cool $98M
Fierce Biotech
Mon, 11/23/20 - 10:16 am
Argenx
Bayer
FDA
priority reviews
efgartigimod
ITP
Biotech Argenx's autoimmune phase 3 hits goals, teeing up FDA filing
Fierce Biotech
Tue, 05/26/20 - 11:07 am
Argenx
efgartigimod
myasthenia gravis
Upcoming events – Wave takes on Huntington's and Argenx goes subcutaneous
EP Vantage
Fri, 11/15/19 - 11:14 am
Wave Life Sciences
WVE-120101
Huntington's disease
Argenx
efgartigimod
autoimmune disease